MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

01 Jun 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has attached a media release on 1st June 2021 titled ‘Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg ‘which is self?explanatory.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..